Mismatch repair and DNA damage signalling

DNA Repair

Volumn 3, Issue 8-9, 2004, Pages 1091-1101

  Stojic, Lovorka ^a   Brun, Richard ^a   Jiricny, Josef ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cell cycle arrest; Checkpoint activation; DNA damage signalling; Ionizing radiation; Methylating agents; Mismatch repair

Indexed keywords

4 O METHYLTHYMINE; 6 O METHYLGUANINE; ABELSON KINASE; ADENINE DERIVATIVE; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; ATM PROTEIN; CISPLATIN; DACARBAZINE; DIMETHYL SULFATE; DNA POLYMERASE; DNA TOPOISOMERASE; GUANINE DERIVATIVE; INTERCALATING AGENT; MESYLIC ACID METHYL ESTER; MITOGEN ACTIVATED PROTEIN KINASE P38; N 3 METHYLADENINE; N 7 METHYLGUANINE; N METHYL N' NITROSOGUANIDINE; N METHYL N' NITROSOUREA; NITROSOGUANIDINE; NITROSOUREA DERIVATIVE; PLATINUM DERIVATIVE; POISON; PROCARBAZINE; STRESS ACTIVATED PROTEIN KINASE; TEMOZOLOMIDE; TIOGUANINE; TRANSPLATIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; CELL CYCLE; CELL KILLING; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION; DNA REPLICATION; DNA SEQUENCE; DRUG EFFECT; DRUG MECHANISM; HOMOLOGOUS RECOMBINATION; HUMAN; IC 50; IONIZING RADIATION; MISMATCH REPAIR; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; BASE PAIR MISMATCH; CELL CYCLE PROTEINS; CISPLATIN; DNA; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; DNA-BINDING PROTEINS; DNA-DIRECTED DNA POLYMERASE; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RADIATION, IONIZING; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION; THIOGUANINE; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

MAMMALIA;

EID: 3242885728     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.06.006     Document Type: Review

References (112)

1. Hsieh P. Molecular mechanisms of DNA mismatch repair. Mutat. Res. 486:2001;71-87
2. Jiricny J. Replication errors: cha(ll)enging the genome. EMBO J. 17:1998;6427-6436
3. Bignami M., Casorelli I., Karran P. Mismatch repair and response to DNA-damaging antitumour therapies. Eur. J. Cancer. 39:2003;2142-2149
4. Li G.M. DNA mismatch repair and cancer. Front. Biosci. 8:2003;997-1017
5. Buermeyer A.B., Deschenes S.M., Baker S.M., Liskay R.M. Mammalian DNA mismatch repair. Ann. Rev. Genet. 33:1999;533-564
6. Lindahl T. Suppression of spontaneous mutagenesis in human cells by DNA base excision-repair. Mutat. Res. 462:2000;129-135
7. de Laat W.L., Jaspers N.G., Hoeijmakers J.H. Molecular mechanism of nucleotide excision repair. Genes Dev. 13:1999;768-785
8. Palombo F., Iaccarino I., Nakajima E., Ikejima M., Shimada T., Jiricny J. hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr. Biol. 6:1996;1181-1184
9. Marra G., Iaccarino I., Lettieri T., Roscilli G., Delmastro P., Jiricny J. Mismatch repair deficiency associated with overexpression of the MSH3 gene. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8568-8573
10. Iaccarino I., Marra G., Dufner P., Jiricny J. Mutation of the magnesium binding site of hMSH6 disables the hMutS-alpha sliding clamp from translocating along DNA. J. Biol. Chem. 275:2000;2080-2086
11. Gradia S., Subramanian D., Wilson T., Acharya S., Makhov A., Griffith J., Fishel R. hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA. Mol. Cell. 3:1999;255-261
12. Blackwell L.J., Martik D., Bjornson K.P., Bjomson E.S., Modrich P. Nucleotide-promoted release of hMutSalpha from heteroduplex DNA is consistent with an ATP-dependent translocation mechanism. J. Biol. Chem. 273:1998;32055-32062
13. Li G.M., Modrich P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1950-1954
14. Holmes J.J., Clark S., Modrich P. Strand-specific mismatch correction in nuclear extracts of human and Drosophila melanogaster cell lines. Proc. Natl. Acad. Sci. U.S.A. 87:1990;5837-5841
15. Genschel J., Modrich P. Mechanism of 5′-directed excision in human mismatch repair. Mol. Cell. 12:2003;1077-1086
16. Fang W.H., Modrich P. Human strand-specific mismatch repair occurs by a bidirectional mechanism similar to that of the bacterial reaction. J. Biol. Chem. 268:1993;11838-11844
17. Fishel R. Signaling mismatch repair in cancer. Nat. Med. 5:1999;1239-1241
18. Dzantiev L., Constantin N., Genschel J., Iyer R.R., Burgers P.M., Modrich P. A defined human system that supports bidirectional mismatch-provoked excision. Mol. Cell. 15:2004;31-41
19. Nystrom-Lahti M., Perrera C., Raschle M., Panyushkina-Seiler E., Marra G., Curci A., Quaresima B., Costanzo F., D'Urso M., Venuta S., Jiricny J. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer. 33:2002;160-167
20. Raschle M., Dufner P., Marra G., Jiricny J. Mutations within the hMLHl and hPMS2 subunits of the human MutLalpha mismatch repair factor affect its ATPase activity, but not its ability to interact with hMutSalpha. J. Biol. Chem. 277:2002;21810-21820
21. Harfe B.D., Jinks-Robertson S. DNA mismatch repair and genetic instability. Ann. Rev. Genet. 34:2000;359-399
22. Scharer O.D., Jiricny J. Recent progress in the biology, chemistry and structural biology of DNA glycosylases. Bioessays. 23:2001;270-281
23. 6- methylguanine residues in E. coli DNA. Nature. 296:1982;868-869
24. Karran P. Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis. 22:2001;1931-1937
25. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6443-6447
26. 6-methylguanine residues elicit DNA repair synthesis by human cell extracts. J. Biol. Chem. 268:1993;15878-15886
27. 6-methylguanine in DNA inhibits replication in vitro by human cell extracts. Biochemistry. 32:1993;13664-13672
28. 6-methylguanine by mismatch correction in human cell extracts. Curr. Biol. 6:1996;1528-1531
29. Cejka P., Stojic L., Mojas N., Russell A.M., Heinimann K., Cannavo E., di Pietro M., Marra G., Jiricny J. Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLHl. EMBO J. 22:2003;2245-2254
30. Wang Y., Qin J. MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation. Proc. Natl. Acad. Sci. U.S.A. 100:2003;15387-15392
31. Cortez D., Guntuku S., Qin J., Elledge S.J. ATR and ATRIP: partners in checkpoint signaling. Science. 294:2001;1713-1716
32. Zou L., Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 300:2003;1542-1548
33. Wang H., Guan J., Perrault A.R., Wang Y., Iliakis G. Replication protein A2 phosphorylation after DNA damage by the coordinated action of Ataxia telangiectasia-mutated and DNA-dependent protein kinase. Cancer Res. 61:2001;8554-8563
34. Vassin V.M., Wold M.S., Borowiec J.A. Replication protein A (RPA) phosphorylation prevents RPA association with replication centers. Mol. Cell Biol. 24:2004;1930-1943
35. Wang Y., Qin J. MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation. Proc. Natl. Acad. Sci. U.S.A. 100:2003;15387-15392
36. Plant J.E., Roberts J.J. A novel mechanism for the inhibition of DNA synthesis following methylation: the effect of N-methyl-N-nitrosourea on HeLa cells. Chem. Biol. Interact. 3:1971;337-342
37. Zhukovskaya N., Branch P., Aquilina G., Karran P. DNA replication arrest and tolerance to DNA methylation damage. Carcinogenesis. 15:1994;2189-2194
38. Kaina B. Critical steps in alkylation-induced aberration formation. Mutat. Res. 404:1998;119-124
39. N1 type methylating agents requires the ATR kinase. Genes Dev. 18:2004;1331-1344
40. Adamson A.W., Kim W.J., Shangary S., Baskaran R., Brown K.D. ATM is activated in response to N-methyl-N′-nitro-N-nitrosoguanidine-induced DNA alkylation. J. Biol. Chem. 277:2002;38222-38229
41. Carethers J.M., Hawn M.T., Chauhan D.P., Luce M.C., Marra G., Koi M., Boland C.R. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N′-nitro-N-nitrosoguanidine. J. Clin. Invest. 98:1996;199-206
42. Debiak M., Nikolova T., Kaina B. Loss of ATM sensitizes against 06-methylguanine triggered apoptosis, SCEs and chromosomal aberrations. DNA Repair (Amst). 3:2004;359-368
43. Morrison C., Sonoda E., Takao N., Shinohara A., Yamamoto K., Takeda S. The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J. 19:2000;463-471
44. Hirose Y., Katayama M., Stokoe D., Haas-Kogan D.A., Berger M.S., Pieper R.O. The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Mol. Cell Biol. 23:2003;8306-8315
45. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2001;2177-2196
46. Swann P.F., Waters T.R., Moulton D.C., Xu Y.Z., Zheng Q., Edwards M., Mace R. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science. 273:1996;1109-1111
47. Hawn M.T., Umar A., Carethers J.M., Marra G., Kunkel T.A., Boland C.R., Koi M. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res. 55:1995;3721-3725
48. Buermeyer A.B., Wilson-Van Patten C., Baker S.M., Liskay R.M. The human MLH1 cDNA complements DNA mismatch repair defects in Mlhl-deficient mouse embryonic fibroblasts. Cancer Res. 59:1999;538-541
49. Yan T., Berry S.E., Desai A.B., Kinsella T.J. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G(2)-M arrest in MMR-proficient RKO cells. Clin. Cancer Res. 9:2003;2327-2334
50. Pan B.F., Nelson J.A. Characterization of the DNA damage in 6-thioguanine-treated cells. Biochem. Pharmacol. 40:1990;1063-1069
51. Yamane K., Taylor K., Kinsella T.J. Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chkl pathway. Biochem. Biophys. Res. Commun. 318:2004;297-302
52. Kandel E.S., Skeen J., Majewski N., Di Cristofano A., Pandolfi P.P., Feliciano C.S., Gartel A., Hay N. Activation of Akt/protein kinase B overcomes a G(2)/M cell cycle checkpoint induced by DNA damage. Mol. Cell Biol. 22:2002;7831-7841
53. Altiok S., Batt D., Altiok N., Papautsky A., Downward J., Roberts T.M., Avraham H. Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells. J. Biol. Chem. 274:1999;32274-32278
54. Wang Q., Zhang H., Fishel R., Greene M.I. BRCA1 and cell signaling. Oncogene. 19:2000;6152-6158
55. Wang Q., Zhang H., Guerrette S., Chen J., Mazurek A., Wilson T., Slupianek A., Skorski T., Fishel R., Greene M.I. Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1. Oncogene. 20:2001;4640-4649
56. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:2000;927-939
57. Jordan P., Carmo-Fonseca M. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol. Life Sci. 57:2000;1229-1235
58. Kartalou M., Essigmann J.M. Recognition of cisplatin adducts by cellular proteins. Mutat. Res. 478:2001;1-21
59. Anthoney D.A., Mcllwrath A.J., Gallagher W.M., Edlin A.R., Brown R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res. 56:1996;1374-1381
60. Mu D., Tursun M., Duckett D.R., Drummond J.T., Modrich P., Sancar A. Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol. Cell Biol. 17:1997;760-769
61. Aebi S., Kurdi-Haidar B., Gordon R., Cenni B., Zheng H., Fink D., Christen R.D., Boland C.R., Koi M., Fishel R., Howell S.B. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56:1996;3087-3090
62. Yamada M., O'Regan E., Brown R., Karran P. Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins. Nucl. Acids Res. 25:1997;491-496
63. Fink D., Nebel S., Norris P.S., Aebi S., Kim H.K., Haas M., Howell S.B. The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells. Br. J. Cancer. 77:1998;703-708
64. Nehme A., Baskaran R., Aebi S., Fink D., Nebel S., Cenni B., Wang J.Y., Howell S.B., Christen R.D. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res. 57:1997;3253-3257
65. Fink D., Zheng H., Nebel S., Norris P.S., Aebi S., Lin T.P., Nehme A., Christen R.D., Haas M., MacLeod C.L., Howell S.B. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res. 57:1997;1841-1845
66. Fink D., Nebel S., Norris P.S., Baergen R.N., Wilczynski S.P., Costa M.J., Haas M., Cannistra S.A., Howell S.B. Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin. Int. J. Cancer. 77:1998;741-746
67. Vaisman A., Varchenko M., Umar A., Kunkel T.A., Risinger J.I., Barrett J.C., Hamilton T.C., Chaney S.G. The role of hMLHl, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res. 58:1998;3579-3585
68. Strathdee G., MacKean M.J., Illand M., Brown R. A role for methylation of the hMLHl promoter in loss of hMLHl expression and drug resistance in ovarian cancer. Oncogene. 18:1999;2335-2341
69. Drummond J.T., Anthoney A., Brown R., Modrich P. Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line. J. Biol. Chem. 271:1996;19645-19648
70. Ferry K.V., Fink D., Johnson S.W., Nebel S., Hamilton T.C., Howell S.B. Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells. Biochem. Pharmacol. 57:1999;861-867
71. Nehme A., Baskaran R., Nebel S., Fink D., Howell S.B., Wang J.Y., Christen R.D. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. Br. J. Cancer. 79:1999;1104-1110
72. Brown R., Hirst G.L., Gallagher W.M., Mcllwrath A.J., Margison G.P., van, der, Zee, Ag D.A., Anthoney hMLHl expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. Oncogene. 15:1997;45-52
73. Aebi S., Fink D., Gordon R., Kim H.K., Zheng H., Fink J.L., Howell S.B. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin. Cancer Res. 3:1997;1763-1767
74. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 22:2003;7265-7279
75. Moggs J.G., Szymkowski D.E., Yamada M., Karran P., Wood R.D. Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucl. Acids Res. 25:1997;480-491
76. Zhao H., Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chkl. Mol. Cell Biol. 21:2001;4129-4139
77. Damia G., Filiberti L., Vikhanskaya F., Carrassa L., Taya Y., D'lncalci M., Broggini M. Cisplatinum and taxol induce different patterns of p53 phosphorylation. Neoplasia. 3:2001;10-16
78. M. Koi, A. Umar, D.P. Chauhan, S.P. Cherian, J.M. Carethers, T.A. Kunkel, C.R. Boland, Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N- nitrosoguanidine tolerance in colon tumor cells with homozygous hMLHl mutation [published erratum appears in Cancer Res. 55 (1995) 201], Cancer Res. 54 (1994) 4308-4312.
79. Umar A., Koi M., Risinger J.I., Glaab W.E., Tindall K.R., Kolodner R.D., Boland C.R., Barrett J.C., Kunkel T.A. Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res. 57:1997;3949-3955
80. Lan Z., Sever-Chroneos Z., Strobeck M.W., Park C.H., Baskaran R., Edelmann W., Leone G., Knudsen E.S. DNA damage invokes mismatch repair-dependent cyclin D1 attenuation and retinoblastoma signaling pathways to inhibit CDK2. J. Biol. Chem. 277:2002;8372-8381
81. Gong J.G., Costanzo A., Yang H.Q., Melino G., Kaelin W.G. Jr., Levrero M., Wang J.Y. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:1999;806-809
82. Shimodaira H., Yoshioka-Yamashita A., Kolodner R.D., Wang J.Y. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc. Natl. Acad. Sci. U.S.A. 100:2003;2420-2425
83. Fritzell J.A., Narayanan L., Baker S.M., Bronner C.E., Andrew S.E., Prolla T.A., Bradley A., Jirik F.R., Liskay R.M., Glazer P.M. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. Cancer Res. 57:1997;5143-5147
84. DeWeese T.L., Shipman J.M., Larrier N.A., Buckley N.M., Kidd L.R., Groopman J.D., Cutler R.G., te Riele H., Nelson W.G. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11915-11920
85. Aquilina G., Crescenzi M., Bignami M. Mismatch repair, G(2)/M cell cycle arrest and lethality after DNA damage. Carcinogenesis. 20:1999;2317-2326
86. Yan T., Schupp J.E., Hwang H.S., Wagner M.W., Berry S.E., Strickfaden S., Veigl M.L., Sedwick W.D., Boothman D.A., Kinsella T.J. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation. Cancer Res. 61:2001;8290-8297
87. Franchitto A., Pichierri P., Piergentili R., Crescenzi M., Bignami M., Palitti F. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase. Oncogene. 22:2003;2110-2120
88. Fedier A., Schwarz V.A., Walt H., Carpini R.D., Haller U., Fink D. Resistance to topoisomerase poisons due to loss of DNA mismatch repair. Int. J. Cancer. 93:2001;571-576
89. Jacob S., Aguado M., Fallik D., Praz F. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res. 61:2001;6555-6562
90. Aquilina G., Ceccotti S., Martinelli S., Hampson R., Bignami M. N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells. Cancer Res. 58:1998;135-141
91. Aquilina G., Ceccotti S., Martinelli S., Soddu S., Crescenzi M., Branch P., Karran P., Bignami M. Mismatch repair and p53 independently affect sensitivity to N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosourea. Clin. Cancer Res. 6:2000;671-680
92. Mellon I., Rajpal D.K., Koi M., Boland C.R., Champe G.N. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science. 272:1996;557-560
93. Leadon S.A., Avrutskaya A.V. Differential involvement of the human mismatch repair proteins, hMLHl and hMSH2, in transcription-coupled repair. Cancer Res. 57:1997;3784-3791
94. Leadon S.A., Avrutskaya A.V. Requirement for DNA mismatch repairproteins in the transcription- coupled repair of thymine glycols in Saccharomyces cerevisiae. Mutat. Res. 407:1998;177-187
95. Sonneveld E., Vrieling H., Mullenders L.H., van A., Hoffen Mouse mismatch repair gene Msh2 is not essential for transcription-coupled repair of UV-induced cyclobutane pyrimidine dimers. Oncogene. 20:2001;538-541
96. Brown K.D., Rathi A., Kamath R., Beardsley D.I., Zhan Q., Mannino J.L., Baskaran R. The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet. 33:2003;80-84
97. Papouli E., Cejka P., Jiricny J. Dependence of the cytotoxicity of DNA damaging agents on the mismatch repair status of human cells. Cancer Res. 64:2004;3391-3394
98. Cejka P., Stojic L., Marra G., Jiricny J. Is mismatch repair really required for ionizing radiation-induced DNA damage signaling? Nat. Genet. 36:2004;432-433
99. D'Atri S., Tentori L., Lacal P.M., Graziani G., Pagani E., Benincasa E., Zambruno G., Bonmassar E., Jiricny J. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol. Pharmacol. 54:1998;334-341
100. Duckett D.R., Bronstein S.M., Taya Y., Modrich P. hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage. Proc. Natl. Acad. Sci. U.S.A. 96:1999;12384-12388
101. Hickman M.J., Samson L.D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10764-10769
102. Chen F., Arseven O.K., Cryns V.L. Proteolysis of the mismatch repair protein MLH1 by caspase-3 promotes DNA damage-induced apoptosis. J. Biol. Chem. 279:2004;27542-27548
103. Hickman M.J., Samson L.D. Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. Mol. Cell. 14:2004;105-116
104. Di Pietro M., Marra G., Cejka P., Stojic L., Menigatti M., Cattaruzza M.S., Jiricny J. Mismatch repair-dependent transcriptome changes in human cells treated with the methylating agent N-methyl-n′-nitro-N-mtrosoguanidine. Cancer Res. 63:2003;8158-8166
105. Lin X., Ramamurthi K., Mishima M., Kondo A., Christen R.D., Howell S.B. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. Cancer Res. 61:2001;1508-1516
106. Yanamadala S., Ljungman M. Potential role of MLH1 in the induction of p53 and apoptosis by blocking transcription on damaged DNA templates. Mol. Cancer Res. 1:2003;747-754
107. Hardman R.A., Afshari C.A., Barrett J.C. Involvement of mammalian MLH1 in the apoptotic response to peroxide-induced oxidative stress. Cancer Res. 61:2001;1392-1397
108. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell Biol. 18:1998;6538-6547
109. Hendrich B., Hardeland U., Ng H.H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature. 401:1999;301-304
110. Bellacosa A., Cicchillitti L., Schepis F., Riccio A., Yeung A.T., Matsumoto Y., Golemis E.A., Genuardi M., Neri G. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3969-3974
111. Cortellino S., Turner D., Masciullo V., Schepis F., Albino D., Daniel R., Skalka A.M., Meropol N.J., Alberti C., Lame L., Bellacosa A. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. Proc. Natl. Acad. Sci. U.S.A. 100:2003;15071-15076
112. Sansom O.J., Zabkiewicz J., Bishop S.M., Guy J., Bird A., Clarke A.R. MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. Oncogene. 22:2003;7130-7136